SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Organovo Holdings, Inc. – ‘8-K’ for 10/10/19 – ‘EX-99.1’

On:  Thursday, 10/10/19, at 6:43pm ET   ·   As of:  10/11/19   ·   For:  10/10/19   ·   Accession #:  1564590-19-36804   ·   File #:  1-35996

Previous ‘8-K’:  ‘8-K’ on 10/3/19 for 10/2/19   ·   Next:  ‘8-K’ on 12/16/19 for 12/13/19   ·   Latest:  ‘8-K’ on 4/23/24 for 4/19/24   ·   24 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/11/19  Organovo Holdings, Inc.           8-K:5,9    10/10/19    2:35K                                    ActiveDisclosure/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     19K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML      6K 


‘EX-99.1’   —   Miscellaneous Exhibit


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C: 

 

Exhibit 99.1

Amendment to Bylaws of Organovo Holdings, Inc.

October 9, 2019

ARTICLE XI – EXCLUSIVE FORUM

Unless the corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another state or federal court located in the State of Delaware) shall, to the fullest extent permitted by law, be the sole and exclusive forum for (1) any derivative action or proceeding brought on behalf of the corporation, (2) any action asserting a claim of breach of a fiduciary duty owed by any director or officer or stockholder of the corporation to the corporation or the corporation’s stockholders, (3) any action arising pursuant to any provision of the DGCL, or these Bylaws or the corporation’s certificate of incorporation (as either may be amended from time to time), or (4) any action asserting a claim governed by the internal affairs doctrine. Any person or entity purchasing or otherwise acquiring or holding any interest in shares of capital stock of the corporation shall be deemed to have notice of and consented to the provisions of this Article XI.  Notwithstanding anything otherwise to the contrary herein, the provisions of this Article XI will not apply to suits brought to enforce a duty or liability created by the federal securities laws or any other claim for which the federal courts have exclusive jurisdiction.

 


Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed as of:10/11/19None on these Dates
Filed on / For Period end:10/10/19
10/9/19
 List all Filings 


24 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/01/23  Organovo Holdings, Inc.           S-8        12/01/23    4:98K                                    Donnelley … Solutions/FA
11/09/23  Organovo Holdings, Inc.           10-Q        9/30/23   61:6.4M                                   Donnelley … Solutions/FA
 8/10/23  Organovo Holdings, Inc.           10-Q        6/30/23   53:5.8M                                   Donnelley … Solutions/FA
 2/09/23  Organovo Holdings, Inc.           10-Q       12/31/22   54:7.1M                                   Donnelley … Solutions/FA
11/10/22  Organovo Holdings, Inc.           10-Q        9/30/22   51:5.6M                                   ActiveDisclosure/FA
10/25/22  Organovo Holdings, Inc.           S-8 POS    10/25/22    3:103K                                   Donnelley … Solutions/FA
10/25/22  Organovo Holdings, Inc.           S-8 POS    10/25/22    3:103K                                   Donnelley … Solutions/FA
10/25/22  Organovo Holdings, Inc.           S-8 POS    10/25/22    3:103K                                   Donnelley … Solutions/FA
10/25/22  Organovo Holdings, Inc.           S-8 POS    10/25/22    3:103K                                   Donnelley … Solutions/FA
10/25/22  Organovo Holdings, Inc.           S-8 POS    10/25/22    3:103K                                   Donnelley … Solutions/FA
10/25/22  Organovo Holdings, Inc.           S-8        10/25/22    6:283K                                   Donnelley … Solutions/FA
 8/11/22  Organovo Holdings, Inc.           10-Q        6/30/22   51:4.7M                                   ActiveDisclosure/FA
 6/10/22  Organovo Holdings, Inc.           10-K        3/31/22   76:8.3M                                   ActiveDisclosure/FA
 2/14/22  Organovo Holdings, Inc.           10-Q       12/31/21   46:5.1M                                   ActiveDisclosure/FA
11/09/21  Organovo Holdings, Inc.           S-8        11/09/21    3:88K                                    Donnelley … Solutions/FA
11/08/21  Organovo Holdings, Inc.           10-Q        9/30/21   43:4.5M                                   ActiveDisclosure/FA
 8/06/21  Organovo Holdings, Inc.           10-Q        6/30/21   41:3.7M                                   ActiveDisclosure/FA
 7/29/21  Organovo Holdings, Inc.           10-K/A      3/31/21   12:1.3M                                   ActiveDisclosure/FA
 6/15/21  Organovo Holdings, Inc.           10-K        3/31/21   74:7.1M                                   ActiveDisclosure/FA
 3/25/21  Organovo Holdings, Inc.           S-8         3/25/21    5:169K                                   Donnelley … Solutions/FA
 2/08/21  Organovo Holdings, Inc.           10-Q       12/31/20   54:5.4M                                   ActiveDisclosure/FA
 1/19/21  Organovo Holdings, Inc.           S-3                    4:993K                                   Donnelley … Solutions/FA
11/05/20  Organovo Holdings, Inc.           10-Q        9/30/20   56:5.5M                                   ActiveDisclosure/FA
 8/10/20  Organovo Holdings, Inc.           10-Q        6/30/20   51:4M                                     ActiveDisclosure/FA
Top
Filing Submission 0001564590-19-036804   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 6:47:39.2pm ET